Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6Y9S

Crystal structure of GSK-3b in complex with the imidazo[1,5-a]pyridine-3-carboxamide inhibitor 16

Summary for 6Y9S
Entry DOI10.2210/pdb6y9s/pdb
DescriptorGlycogen synthase kinase-3 beta, ~{N}-(oxan-4-ylmethyl)-6-(5-propan-2-yloxypyridin-3-yl)imidazo[1,5-a]pyridine-3-carboxamide, ACETATE ION, ... (4 entities in total)
Functional Keywordsglycogen synthase kinase-3 beta, indazole, inhibitor, kinase, transferase, proteros biostructures gmbh
Biological sourceHomo sapiens (Human)
Total number of polymer chains2
Total formula weight80731.61
Authors
Krapp, S.,Griessner, A.,Blaesse, M.,Buonfiglio, R.,Ombrato, R. (deposition date: 2020-03-10, release date: 2020-05-20, Last modification date: 2024-10-23)
Primary citationBuonfiglio, R.,Prati, F.,Bischetti, M.,Cavarischia, C.,Furlotti, G.,Ombrato, R.
Discovery of Novel Imidazopyridine GSK-3 beta Inhibitors Supported by Computational Approaches.
Molecules, 25:-, 2020
Cited by
PubMed Abstract: The interest of research groups and pharmaceutical companies to discover novel GSK-3β inhibitors has increased over the years considering the involvement of this enzyme in many pathophysiological processes and diseases. Along this line, we recently reported on 1H-indazole-3-carboxamide (INDZ) derivatives -, showing good GSK-3β inhibition activity. However, they suffered from generally poor central nervous system (CNS) permeability. Here, we describe the design, synthesis, and in vitro characterization of novel imidazo[1,5-a]pyridine-1-carboxamide (IMID 1) and imidazo[1,5-a]pyridine-3-carboxamide (IMID 2) compounds (-) to overcome such liability. In detail, structure-based approaches and fine-tuning of physicochemical properties guided the design of derivatives - resulting in ameliorated absorption, distribution, metabolism, and excretion (ADME) properties. A crystal structure of in complex with GSK-3β enzyme (PDB entry 6Y9S) confirmed the in silico models. Despite the nanomolar inhibition activity, the new core compounds showed a reduction in potency with respect to INDZ derivatives -. In this context, Molecular Dynamics (MD) and Quantum Mechanics (QM) based approaches along with NMR investigation helped to rationalize the observed structure activity relationship (SAR). With these findings, the key role of the acidic hydrogen of the central core for a tight interaction within the ATP pocket of the enzyme reflecting in good GSK-3β affinity was demonstrated.
PubMed: 32380735
DOI: 10.3390/molecules25092163
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.03 Å)
Structure validation

239492

數據於2025-07-30公開中

PDB statisticsPDBj update infoContact PDBjnumon